---
name: MD-BEX-FINAL-RUNTIME-4-BINDING-PATCH-RESULT
description: Certification of the final 4-point runtime patch for Tax LP, Kanitz Metadata, Derived SSOT, and Safe Pagination.
type: feature
---
# BEX & Kanitz Final Runtime 4-Binding Patch Certification

**Status:** BEX_KANITZ_MULTI_BALANCETE_PRODUCTION_HOMOLOGATED
**Version:** 1.0 (Core Frozen)
**Date:** 2026-08-11

## 1. Core Freeze Verification
- ACCOUNTING_CORE_FREEZE: **TRUE**
- CANONICAL_FACT_REGISTRY_FREEZE: **TRUE**
- SOURCE_BINDING_FREEZE: **TRUE**
- KANITZ_CORE_FREEZE: **TRUE**

## 2. Patch Implementation Matrix

| Patch | Feature | Status | Evidence |
| :--- | :--- | :--- | :--- |
| **PATCH-01** | Tax LP Consumer Binding | **PASS** | `tax.noncurrent` bound to `residual_facts.tax.noncurrent_obligations`. R$ 131.427 asserted for March/May. |
| **PATCH-02** | Kanitz Company Metadata | **PASS** | Kanitz now consumes `DocumentMetadataRegistry`. "GERATHERM MEDICAL LATIN AMÉRICA LTDA" asserted. |
| **PATCH-03** | Derived Fact SSOT | **PASS** | Coverage and EBITDA unified via `residualFactsResolver`. Mismatch between BEx/Kanitz eliminated. |
| **PATCH-04** | BEx Safe Pagination | **PASS** | `245mm` max-height and `pageBreakBefore` applied to Pages 3/4. No content clipping. |

## 3. Financial Parity Assertion (Golden Test)

| Period | PL (BEx/Kanitz) | Revenue (BEx) | Tax LP (BEx) | Coverage (BEx/Kanitz) | Result |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **March/26** | -R$ 5.814.097 | R$ 2.904.639 | R$ 131.427 | -1,31x (Unified) | **PASS** |
| **May/26** | -R$ 6.905.038 | R$ 3.914.486 | R$ 131.427 | -0,04x (Unified) | **PASS** |

## 4. Final Homologation Decision
The audit engine is now fully certified for production. Residual runtime bindings have been corrected without mutating the accounting core.

**BEX_KANITZ_MULTI_BALANCETE_PRODUCTION_HOMOLOGATED = YES**
